The Evolution of Pandemic Clones of Methicillin-Resistant Staphylococcus aureus: Identification of Two Ancestral Genetic Backgrounds and the Associated mec …

DC Oliveira, A Tomasz, H de Lencastre - Microbial Drug Resistance, 2001 - liebertpub.com
DC Oliveira, A Tomasz, H de Lencastre
Microbial Drug Resistance, 2001liebertpub.com
Previous surveillance studies carried out by our laboratories, primarily in Southern and
Eastern Europe, Latin America, and the United States, have characterized 3,067 methicillin-
resistant Staphylococcus aureus (MRSA) hospital isolates by a combination of molecular
typing methods. Nearly 70% of these isolates could be classified into five clonal types
showing extensive geographic spread. Representative isolates of these clonal types were
now reexamined for their genetic relatedness by multilocus sequence typing (MLST) and by …
Previous surveillance studies carried out by our laboratories, primarily in Southern and Eastern Europe, Latin America, and the United States, have characterized 3,067 methicillin-resistant Staphylococcus aureus (MRSA) hospital isolates by a combination of molecular typing methods. Nearly 70% of these isolates could be classified into five clonal types showing extensive geographic spread. Representative isolates of these clonal types were now reexamined for their genetic relatedness by multilocus sequence typing (MLST) and by sequencing the polymorphic region of protein A (spaA typing), and also for the type of the Staphylococcal Chromosomal Cassette (SCCmec) resident in the bacteria. Three of the previously classified clonal types (Iberian, Brazilian, and Hungarian clones) shared a common or closely related genetic background A, which was the same as the background of the earliest European isolates of MRSA from England and Denmark. The Pediatric and New York/Japan clones belonged to a completely different genetic background B. The three recently described SCCmec types were specifically associated with different pandemic clones: types I and III with isolates of genetic background A and type II with isolates of genetic background B. A novel SCCmec related to type I, called SCCmec type IV, was identified in some MRSA strains belonging to genetic background A as well as B. Structural variations in SCCmec types I and III were also observed. The data allow tentative identification of an evolutionary pathway for the emergence of pandemic MRSA clones and also provide evidence for the multiple, yet restricted, numbers of acquisition of the mec element by S. aureus.
Mary Ann Liebert